Branched-chain amino acids in the management of hepatic encephalopathy: an analysis of variants (Q38659122)

5 September 2017

1 reference

title

Branched-chain amino acids in the management of hepatic encephalopathy: an analysis of variants (English)

1 reference

5 September 2017

hepatic encephalopathy

1 reference

Eriksson LS

1

1 reference

PubMed ID

2663696

5 September 2017

Conn HO

series ordinal

2

1 reference

PubMed ID

2663696

5 September 2017

language of work or name

English

0 references

publication date

1 August 1989

1 reference

5 September 2017

1 reference

5 September 2017

10

1 reference

5 September 2017

2

1 reference

5 September 2017

228-246

1 reference

Stimulation of albumin synthesis by keto analogues of amino acids

5 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

False neurotransmitters and hepatic failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

EVIDENCE FOR A FALSE NEUROCHEMICAL TRANSMITTER AS A MECHANISM FOR THE HYPOTENSIVE EFFECT OF MONOAMINE OXIDASE INHIBITORS

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

False adrenergic transmitters

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Urinary and serum octopamine in patients with portal-systemic encephalopathy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Plasma phenylethanolamine in hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Plasma amino acids in patients with hepatic encephalopathy. Effects of amino acid infusions.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Free amino acids in liver, plasma, and muscle of patients with cirrhosis of the liver

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Amino acid assignment to one of three blood-brain barrier amino acid carriers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Brain Serotonin Content: Physiological Regulation by Plasma Neutral Amino Acids

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Blood-brain neutral amino acid transport activity is increased after portacaval anastomosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Hyperammonaemia, plasma aminoacid imbalance, and blood-brain aminoacid transport: a unified theory of portal-systemic encephalopathy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Dopamine and Serotonin Metabolism in Hepatic Encephalopathy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Tryptophan and 5-hydroxyindoleacetic acid in human cerebrospinal fluid.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Effect of starvation on the turnover and metabolic response to leucine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Influence of leucine on arterial concentrations and regional exchange of amino acids in healthy subjects

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

A comparison of the effects of intravenous infusion of individual branched-chain amino acids on blood amino acid levels in man

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Effect of glucose and/or branched chain amino acid infusion on plasma amino acid imbalance in chronic liver failure

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Leucine. A possible regulator of protein turnover in muscle

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Amino acid derangements in patients with sepsis: treatment with branched chain amino acid rich infusions

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Branched chain metabolic support. A prospective, randomized, double-blind trial in surgical stress

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Branched-chain amino acids vs lactulose in the treatment of hepatic coma: a controlled study.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Use of branched chain amino acids for treating hepatic encephalopathy: clinical experiences.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Disease-specific amino acid infusion (F080) in hepatic encephalopathy: a prospective, randomized, double-blind, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Treatment of acute hepatic encephalopathy in cirrhotics with a branched-chain amino acids enriched versus a conventional amino acids mixture. A controlled study of 70 patients.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Survival prediction in portacaval shunts: A computerized statistical analysis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Assessment of coma and impaired consciousness. A practical scale

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Branched-chain amino acids in the treatment of chronic hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Comparison of the effects of Hepatic-Aid and a Casein modular diet on encephalopathy, plasma amino acids, and nitrogen balance in cirrhotic patients.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Portal-systemic encephalopathy. Influence of shunt surgery and relations to serum amino acids.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Psychomotor performance defects in cirrhotic patients without overt encephalopathy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Standard or branched-chain amino acid infusions as short-term nutritional support in liver cirrhosis?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Enriched branched-chain amino acid formula versus a casein-based supplement in the treatment of cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Branched chain amino acid-enriched solutions in the septic patient. A randomized, prospective trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Treatment of Carbamyl Phosphate Synthetase Deficiency with Keto Analogues of Essential Amino Acids

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Neonatal citrllinemia: treatment with keto-analogues of essential amino acids

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Effect of protein ingestion on splanchnic and leg metabolism in normal man and in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Influence of branched-chain amino acids and branched-chain keto acids on protein synthesis in isolated hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

The use of ornithine salts of branched-chain ketoacids in portal-systemic encephalopathy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

The electroencephalograph in liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Effect of ornithine alpha oxoglutarate on brain metabolism in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Oral keto analogs of branched-chain amino acids in hyperammonemia in patients with cirrhosis of the liver. A double-blind crossover study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Plasma amino acids imbalance in patients with liver disease.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Amino acids in liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Plasma ratio of valine, leucine and isoleucine to phenylalanine and tyrosine in liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Hyperglucagonemia in Laennec's cirrhosis. The role of portal-systemic shunting

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Effect of ammonia on plasma and cerebrospinal fluid amino acids in dogs with and without portacaval anastomoses

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Chemical Nature of Synaptic Transmission in Vertebrates

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Can hepatic coma be caused by a reduction of brain noradrenaline or dopamine?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Levodopa in hepatic coma.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Reversal of ammonia coma in rats by L-dopa: a peripheral effect

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100218

7 January 2021

Identifiers

DOI

10.1002/HEP.1840100218

1 reference

5 September 2017

1 reference

PubMed ID

2663696